Maito Suoh
Overview
Explore the profile of Maito Suoh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Suoh M, Esmaili S, Eslam M, George J
Hepatol Int
. 2024 Oct;
18(6):1740-1755.
PMID: 39412611
Background: The international consensus to revise non-alcoholic fatty liver disease to metabolic (dysfunction)-associated fatty liver disease (MAFLD) in 2020 attracted significant attention. The impact of the MAFLD definition on the...
3.
Suoh M, Hagihara A, Kageyama K, Yamamoto A, Enomoto M, Tamori A, et al.
Intern Med
. 2021 Feb;
60(14):2223-2228.
PMID: 33612670
An 87-year-old man with hepatocellular carcinoma (HCC) presented with right-sided chest pain. Computed tomography revealed right bloody pleural effusion and an extravasation from an arterially enhanced mass in the right...
4.
Suoh M, Hagihara A, Yamamura M, Maruyama H, Taira K, Enomoto M, et al.
Intern Med
. 2020 Oct;
60(4):545-552.
PMID: 33028766
An 82-year-old man with hepatocellular carcinoma presented with upper abdominal pain, vomiting, and jaundice. He had been taking a standard lenvatinib dose for three months. Although acute cholangitis was suggested,...
5.
Odagiri N, Hai H, Thuy L, Dong M, Suoh M, Kotani K, et al.
Cancers (Basel)
. 2020 Jul;
12(8).
PMID: 32722224
Immune checkpoint inhibitors, combined with anti-angiogenic agents or locoregional treatments (e.g., transarterial chemoembolization (TACE)), are expected to become standard-of-care for unresectable hepatocellular carcinoma (HCC). We measured the plasma levels of...
6.
Suoh M, Fujii H, Nagata Y, Kotani K, Hagihara A, Enomoto M, et al.
Clin J Gastroenterol
. 2020 Mar;
13(5):860-866.
PMID: 32128670
Hypothyroidism is a common adverse event of lenvatinib therapy for hepatocellular carcinoma (HCC), whereas thyrotoxicosis has rarely been reported in clinical trials. A 74-year-old man complaining of abdominal pain was...
7.
Suoh M, Tamori A, Amano-Teranishi Y, Nakai T, Enomoto M, Kawasaki Y, et al.
Intern Med
. 2020 Jan;
59(2):205-210.
PMID: 31941870
The appropriate management of hepatitis B virus (HBV) infection during pregnancy has not been established in Japan. We herein report five HBV-infected pregnant Japanese women who received tenofovir disoproxil fumarate...
8.
Thuy L, Matsumoto Y, Thuy T, Hai H, Suoh M, Urahara Y, et al.
Am J Pathol
. 2015 Feb;
185(4):1045-60.
PMID: 25665792
This study was conducted to clarify the role of cytoglobin (Cygb), a globin expressed in hepatic stellate cells (HSCs), in the development of liver fibrosis and cancer in nonalcoholic steatohepatitis...